CVS Health Corporation (NYSE:CVS) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now.
Photo by
NeONBRAND on
Unsplash
CVS Health Corporation (NYSE:CVS), an American multinational healthcare company, received renewed confidence from Cantor Fitzgerald on October 10, as the firm reaffirmed its Overweight rating on the stock. The stock has surged by over 80% since the start of 2025.
According to the research note, the slight drop in the company’s Medicare Advantage Star ratings was “more positive than feared” and represented “the largest upside in ratings” among peers. Cantor Fitzgerald expects a favorable market reaction, pointing out that CVS has maintained over 80% of its ratings at high levels.
The firm added that earlier in the quarter, concerns had arisen overCVS Health Corporation (NYSE:CVS)’s ability to sustain its strong position in the Medicare Star Ratings program, which plays a critical role in determining reimbursement rates and enrollment opportunities for Medicare Advantage plans. These ratings are particularly important for CVS, as its Medicare Advantage business makes up a large portion of its healthcare benefits division.
CVS Health Corporation (NYSE:CVS)’s dividend also continues to attract investor attention, with the company maintaining a consistent payout record since 1997. The company’s quarterly dividend comes in at $0.665 per share and has a dividend yield of 3.35%, as of October 14.
While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 11 Low PE High Dividend Stocks to Buy According to Analysts and 12 Reliable Dividend Stocks for Maximum Income.
Disclosure: None.